Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.

ABSTRACT:

Objectives

Human papillomavirus (HPV) testing for cervical screening has been shown to increase the yield of precancerous disease and reduce the incidence of cervical cancer more than cytology alone. Here we document the state-wide uptake of co-testing with HPV and cytology in women aged 30-64 years as recommended by national and international bodies.

Methods

Registry-based study of all screening cytology and HPV tests in New Mexico from 2008 to 2019 among women aged 21-64 years, with a focus on cytology negative tests to distinguish co-testing from reflex HPV testing to triage equivocal or mildly abnormal cytology.

Results

A total of 1,704,055 cervical screening tests from 681,440 women aged 21-64 years in the state of New Mexico were identified. The proportion of sc

SUBMITTER: Cuzick J 

PROVIDER: S-EPMC8405560 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature